HERPES VIRUS (HHV 4) - EPSTEIN-BARR VIRUS (EBV) - ANVISA Registration 80146501839

Access comprehensive regulatory information for HERPES VIRUS (HHV 4) - EPSTEIN-BARR VIRUS (EBV) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80146501839 and manufactured by ABBOTT GMBH. The registration is held by ABBOTT LABORATORIOS DO BRASIL LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including ABBOTT GMBH, SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD., and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
80146501839
Registration Details
ANVISA Registration Number: 80146501839
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Device Details

Registration Details

80146501839

25351250609201311

56998701000116

Company Information

ABBOTT GMBH
Germany
PT: ALEMANHA

Dates and Status

Jun 24, 2013

VIGENTE

09/18/2025 19:00:01